Portugal Pharmaceuticals and Healthcare Report Q1 2013Business Monitor International
January 16, 2013
91 Pages - SKU: BMI4944003
More Prescription Drugs reports by Business Monitor International
Kuwait Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Opportunities in Kuwait's healthcare and pharmaceuticals market are limited, given its smallpopulation, limited domestic drug production and the high proportion of expatriates. The ...
Italy Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: The sharp drop in public pharmaceutical expenditure in Italy in 2012 to a level below that of2001 does not bode well for drugmakers ...
Tanzania Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Tanzania, ...
Singapore Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
BMI View: Unlike other developed Asia Pacific countries, we note that the Singaporean government isseeking to increase its share of healthcare expenditure in light of ...
More Portugal Prescription Drugs reports
Portugal Pharmaceuticals and Healthcare Q4 2012 by Business Monitor International
BMI View: Portugal continues to implement widespread changes to its healthcare sector as part of theEU/IMF/ECB’s EUR78bn economic rescue package approved in May 2011, and ...
Antibiotics Market in Portugal to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Portugal. The study provides essential market ...
The Pharmaceutical Market: Portugal by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Portugal Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor InternationalSee all reports like this >>
BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measureshave taken their toll on all sectors – including ...
More Portugal reports
D&B Country Report: Portugal by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
D&B Country RiskLine Report: Portugal by Dun & Bradstreet Inc.See all reports like this >>
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports
- Kuwait Pharmaceuticals and Healthcare Report Q3 2013
- Italy Pharmaceuticals and Healthcare Report Q3 2013
- Taiwan Pharmaceutical Market Outlook 2013
- China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Impo
- Tanzania Pharmaceuticals and Healthcare Report Q3 2013